Literature DB >> 11287057

Panic-agoraphobic spectrum: reliability and validity of assessment instruments.

M K Shear1, E Frank, P Rucci, D A Fagiolini, V J Grochocinski, P Houck, G B Cassano, D J Kupfer, J Endicott, J D Maser, M Mauri, S Banti.   

Abstract

DSM IV is a simple, reliable diagnostic system with many advantages. However, DSM diagnostic criteria may not provide sufficient characterization of clinically significant symptoms. We have undertaken a project to assess an array (spectrum) of clinical features associated with different DSM Disorders. The purpose of this paper is to report on reliability of assessment instruments for Panic-Agoraphobic Spectrum (PAS), to document convergent validity of PAS symptom groupings, and to confirm the relationship between PAS and DSM IV Panic Disorder (PD). We studied 22 normal controls and 95 outpatients who met criteria for Panic Disorder with and without lifetime Major Depression, and Major Depression or Obsessive Compulsive Disorder without lifetime Panic Disorder. Assessment instruments had excellent reliability and there was good concordance between interview and self-report formats. PAS scores were highest in subjects with PD, followed by outpatients without PD, and were lowest in normal controls. PAS scores varied among PD patients, and a subgroup of patients without PD scored high on PAS. We conclude that PAS can be reliably assessed, and that it describes a valid, coherent constellation of features associated with DSM IV Panic Disorder, but providing additional important clinical information.

Entities:  

Mesh:

Year:  2001        PMID: 11287057     DOI: 10.1016/s0022-3956(01)00002-4

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  18 in total

1.  Does psychomotor retardation define a clinically relevant phenotype of unipolar depression?

Authors:  S Calugi; G B Cassano; A Litta; P Rucci; A Benvenuti; M Miniati; L Lattanzi; V Mantua; V Lombardi; A Fagiolini; E Frank
Journal:  J Affect Disord       Date:  2010-09-15       Impact factor: 4.839

2.  Psychotherapy Alone and Combined With Medication as Treatments for Bipolar II Depression: A Randomized Controlled Trial.

Authors:  Holly A Swartz; Paola Rucci; Michael E Thase; Meredith Wallace; Elisa Carretta; Karen L Celedonia; Ellen Frank
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

3.  Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.

Authors:  E Frank; G B Cassano; P Rucci; W K Thompson; H C Kraemer; A Fagiolini; L Maggi; D J Kupfer; M K Shear; P R Houck; S Calugi; V J Grochocinski; P Scocco; J Buttenfield; R N Forgione
Journal:  Psychol Med       Date:  2010-04-12       Impact factor: 7.723

4.  Therapist Use of Specific and Nonspecific Strategies Across Two Affect-Focused Psychotherapies for Depression: Role of Adherence Monitoring.

Authors:  Marlissa C Amole; Jill M Cyranowski; Laren R Conklin; John C Markowitz; Stacy E Martin; Holly A Swartz
Journal:  J Psychother Integr       Date:  2016-06-06

5.  Cross-cultural validity of the structured clinical interview for panic-agoraphobic spectrum.

Authors:  Ellen Frank; M Katherine Shear; Paola Rucci; Susanna Banti; Mauro Mauri; Jack D Maser; David J Kupfer; Mario Miniati; Andrea Fagiolini; Giovanni B Cassano
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-04       Impact factor: 4.328

6.  Treating co-occurring depression and anxiety: modeling the dynamics of psychopathology and psychotherapy using the time-varying effect model.

Authors:  Aidan G C Wright; Michael N Hallquist; Holly A Swartz; Ellen Frank; Jill M Cyranowski
Journal:  J Consult Clin Psychol       Date:  2013-09-16

Review 7.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

8.  Current diagnosis and treatment of anxiety disorders.

Authors:  Alexander Bystritsky; Sahib S Khalsa; Michael E Cameron; Jason Schiffman
Journal:  P T       Date:  2013-01

9.  Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression.

Authors:  Jean-Philippe Guilloux; Sabrina Bassi; Ying Ding; Chris Walsh; Gustavo Turecki; George Tseng; Jill M Cyranowski; Etienne Sibille
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

10.  Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

Authors:  Antonella Benvenuti; Paola Rucci; Simona Calugi; Giovanni B Cassano; Mario Miniati; Ellen Frank
Journal:  Int Clin Psychopharmacol       Date:  2010-03       Impact factor: 1.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.